Mutant calreticulin enables potent and selective CAR-T cell therapy in preclinical models of myeloproliferative neoplasms

Pesini, Cecilia Gil-Bellido, Mario Millán, Lorena S. Oñate, Carmen Calvo-Pérez, Adanays Santiago, Llipsy Iglesias, Eldris Bernal, Jorge Paúl Araujo-Voces, Miguel Paz Artigas, Laura García-Martínez, Laura Roig, Francisco J Movilla Meno, Nieves Garcia-Aznar, José Manuel Menéndez-Jandula, Bárbara Olave, María Teresa Azaceta Reinares, Gemma Garrote, Marta Alvarez-Larrán, Alberto Gálvez, Eva M Sánchez Martínez, Diego Arias, Maykel A Pardo, Julian Ramirez-Labrada, Ariel Mutant calreticulin enables potent and selective CAR-T cell therapy in preclinical models of myeloproliferative neoplasms

J. immunotherap. cancer

10.1136/jitc-2025-012706 2026

2026